How effective is Clarinex for Allergic Rhinitis? (a real world drug study)

Summary:

Overall ratings: 3.5/5
Long term ratings: 3.5/5

This is a phase IV clinical study of how effective Clarinex (desloratadine) is for Allergic rhinitis and for what kind of people. The study is created by eHealthMe from 4 Clarinex users and is updated continuously.

What is Clarinex?

Clarinex has active ingredients of desloratadine. It is often used in allergies. eHealthMe is studying from 6,463 Clarinex users. Check the latest studies of Clarinex.

What is Allergic rhinitis?

Allergic rhinitis is found to be associated with 910 drugs and 1,316 conditions by eHealthMe. Check the latest studies of Allergic rhinitis.


On Aug, 01, 2026

4 people are studied for taking Clarinex in Allergic rhinitis

Overall effectiveness (number of people):

Does Clarinex work for your Allergic rhinitis (overall)?

Long term (1+ years) effectiveness (number of people):

Does Clarinex work for your Allergic rhinitis (long term)?

Clarinex effectiveness for Allergic rhinitis (number of people):

Overall:
  • not at all: 0
  • somewhat: 0
  • moderate: 2
  • high: 2
  • very high: 0
Long Term:
  • not at all: 0
  • somewhat: 0
  • moderate: 1
  • high: 1
  • very high: 0

Gender of people who take Clarinex for Allergic rhinitis *:

  • female: 50 %
  • male: 50 %

Age of people who take Clarinex for Allergic rhinitis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 25 %
  • 50-59: 50 %
  • 60+: 25 %

Who find Clarinex more effective for Allergic Rhinitis?

Gender of people who take Clarinex for Allergic rhinitis *:

  • female: 50 %
  • male: 50 %

Age of people who take Clarinex for Allergic rhinitis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 50 %
  • 50-59: 50 %
  • 60+: 0.0 %

* Approximation only. Some reports may have incomplete information.

Do you take Clarinex?

- You can start a phase IV clinical trial to monitor Clarinex safety and effectiveness.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Alternative drugs to, pros and cons of:

Treatments, associated drugs and conditions:

How the study uses the data?

The study is based on desloratadine (the active ingredients of Clarinex) and Clarinex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: